高级检索
当前位置: 首页 > 详情页

Cardioprotective effects of glycyrrhizic acid involve inhibition of calcium influx via L-type calcium channels and myocardial contraction in rats

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Hebei Univ Chinese Med, Sch Pharm, Shijiazhuang 050200, Hebei, Peoples R China [2]Hebei Key Lab Integrat Med Liver Kidney Patterns, Shijiazhuang 050200, Hebei, Peoples R China [3]Hebei Univ Chinese Med, Sch Basic Med, Shijiazhuang 050200, Hebei, Peoples R China [4]Hebei Med Univ, Affiliated Hosp 4, Shijiazhuang 050011, Hebei, Peoples R China [5]Hebei Univ Chinese Med, Affiliated Hosp, Shijiazhuang 050011, Hebei, Peoples R China
出处:
ISSN:

关键词: Glycyrrhizic acid L-type Ca2+ current Cell contraction Ca2+ transient

摘要:
Glycyrrhizic acid (GA) is one of the main active components in licorice and has often been reported to have cardioprotective effects. However, the underlying cellular mechanisms remain unclear. The aim of this study is to verify the protective effects of GA against isoproterenol (ISO)-induced myocardial ischemia injury in rats. Another aim is to explore the cellular mechanisms based on the L-type Ca2+ channel, myocardial cell contraction, and intracellular Ca2+ ([Ca2+](i)) transient. The results show that GA reduced the ST segment elevation, decreased the heart rate, prevented ISO-induced QT-interval shortening, improved heart morphology, and decreased the activity of CK and LDH. GA blocked ICa-L in a dose-dependent manner. The concentration for 50% of the maximal effect (EC50) of GA was 145.54 mu g/mL, and the maximal inhibition was 47.43 +/- 0.75% at 1000 mu g/mL. However, GA did not affect the dynamical properties of the Ca2+ channel. GA reversibly reduced the amplitude of cell contraction in a dose-dependent manner and slowed down its deflection and recovery, as well as the [Ca2+](i) transient. The data demonstrate that GA inhibits L-type Ca2+ channels, decreases the [Ca2+](i) transient, and shows a negative cardiac inotropic effect in the ventricular myocardial cells of adult rats. It also protects the myocardia from ischemia injury induced by ISO.

基金:

基金编号: ZD2018038 ZD2016091 2019075 2019135

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 药学
JCR分区:
出版当年[2020]版:
Q3 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q2 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Hebei Univ Chinese Med, Sch Pharm, Shijiazhuang 050200, Hebei, Peoples R China
通讯作者:
通讯机构: [1]Hebei Univ Chinese Med, Sch Pharm, Shijiazhuang 050200, Hebei, Peoples R China [2]Hebei Key Lab Integrat Med Liver Kidney Patterns, Shijiazhuang 050200, Hebei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号